Cargando…

A nomogram prediction for the survival of patients with triple negative breast cancer

Triple negative breast cancer (TNBC) is a subtype of breast cancer with poor prognosis. In this study, we aimed to conduct a nomogram to predict the survival of individual with TNBC by incorporating significant clinical and laboratory parameters. 404 TNBC patients from the Affiliated Union Hospital...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Yuxiang, Fu, Fangmeng, Lin, Songping, Qiu, Wei, Zhou, Wei, Lv, Jinxing, Wang, Chuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114947/ https://www.ncbi.nlm.nih.gov/pubmed/30181802 http://dx.doi.org/10.18632/oncotarget.24964

Ejemplares similares

Polymorphisms of long non-coding RNA HOTAIR with breast cancer susceptibility and clinical outcomes for a southeast Chinese Han population
por: Lin, Yuxiang, et al.
Publicado: (2017)

Genetic variants in long noncoding RNA H19 contribute to the risk of breast cancer in a southeast China Han population
por: Lin, Yuxiang, et al.
Publicado: (2017)

LncRNA PCIR Is an Oncogenic Driver via Strengthen the Binding of TAB3 and PABPC4 in Triple Negative Breast Cancer
por: Guo, Wenhui, et al.
Publicado: (2021)

Development and validation of nomograms predicting survival in Chinese patients with triple negative breast cancer
por: Yang, Yaping, et al.
Publicado: (2019)

Subtype-specific associations between breast cancer risk polymorphisms and the survival of early-stage breast cancer
por: Fu, Fangmeng, et al.
Publicado: (2018)

Development and validation of nomograms for predicting overall and breast cancer-specific survival among patients with triple-negative breast cancer
por: Guo, Lin-Wei, et al.
Publicado: (2018)

Nomogram for predicting overall survival in Chinese triple-negative breast cancer patients after surgery
por: Lin, Wei-Xun, et al.
Publicado: (2022)

Identification of potential key genes for HER-2 positive breast cancer based on bioinformatics analysis
por: Lin, Yuxiang, et al.
Publicado: (2020)

Transcriptional Expressions of CXCL9/10/12/13 as Prognosis Factors in Breast Cancer
por: Li, Yan, et al.
Publicado: (2020)

Thrombospondin 2 is a Functional Predictive and Prognostic Biomarker for Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy
por: Lin, Yuxiang, et al.
Publicado: (2022)

Development and validation of nomograms for predicting survival in patients with de novo metastatic triple-negative breast cancer
por: Chen, Mao-Shan, et al.
Publicado: (2022)

Evaluating the Survival Benefit Following Ovarian Function Suppression in Premenopausal Patients with Hormone Receptor Positive Early Breast Cancer
por: Qiu, Lin, et al.
Publicado: (2016)

Construction and Validation of Nomograms Predicting Survival in Triple-Negative Breast Cancer Patients of Childbearing Age
por: Cui, Xiang, et al.
Publicado: (2021)

CTPS1 promotes malignant progression of triple-negative breast cancer with transcriptional activation by YBX1
por: Lin, Yuxiang, et al.
Publicado: (2022)

The precision relationships between eight GWAS-identified genetic variants and breast cancer in a Chinese population
por: Chen, Yazhen, et al.
Publicado: (2016)

Dual HER2 Blockade versus a Single Agent in Trastuzumab-Containing Regimens for HER2-Positive Early Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Yu, Liuwen, et al.
Publicado: (2020)

Nomogram for Predicting Lymph Node Involvement in Triple-Negative Breast Cancer
por: Cui, Xiang, et al.
Publicado: (2020)

A Nomogram to Predict Disease-Free Survival Following Neoadjuvant Chemotherapy for Triple Negative Breast Cancer
por: Zhu, Meizhen, et al.
Publicado: (2021)

Nomogram Personalizes and Visualizes the Overall Survival of Patients with Triple-Negative Breast Cancer Based on the Immune Genome
por: Wang, Peipei, et al.
Publicado: (2020)

A Combined Nomogram Model to Predict Disease-free Survival in Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy
por: Xia, Bingqing, et al.
Publicado: (2021)

Nomograms predicting overall survival and cancer-specific survival in osteosarcoma patients (STROBE)
por: Chen, Wenhao, et al.
Publicado: (2019)

TTK is a favorable prognostic biomarker for triple-negative breast cancer survival
por: Xu, Qianqian, et al.
Publicado: (2016)

LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer
por: Lv, Mingming, et al.
Publicado: (2016)

YTHDF3 facilitates triple-negative breast cancer progression and metastasis by stabilizing ZEB1 mRNA in an m(6)A-dependent manner
por: Lin, Yuxiang, et al.
Publicado: (2022)

Associations of Two Common Genetic Variants with Breast Cancer Risk in a Chinese Population: A Stratified Interaction Analysis
por: Lin, Yuxiang, et al.
Publicado: (2014)

Development and Validation of Nomograms for Predicting the Prognosis of Triple-Negative Breast Cancer Patients Based on 379 Chinese Patients
por: Shi, Hao, et al.
Publicado: (2019)

Establishment and verification of a nomogram for predicting survival in patients with triple-positive breast cancer
por: Wang, Xingguang, et al.
Publicado: (2022)

Nomogram for predicting overall survival in patients with triple-negative apocrine breast cancer: Surveillance, epidemiology, and end results-based analysis
por: Xu, Yinggang, et al.
Publicado: (2022)

Diagnostic and Prognostic Nomograms for Lung Metastasis in Triple-Negative Breast Cancer
por: Wang, Jianguo, et al.
Publicado: (2022)

Survival outcome assessment for triple-negative breast cancer: a nomogram analysis based on integrated clinicopathological, sonographic, and mammographic characteristics
por: Sheng, Dan-li, et al.
Publicado: (2022)

Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
por: Qiu, Jingdan, et al.
Publicado: (2016)

SPHK1 regulates proliferation and survival responses in triple-negative breast cancer
por: Datta, Arpita, et al.
Publicado: (2014)

Three-microRNA expression signature predicts survival in triple-negative breast cancer
por: Wu, Xinquan, et al.
Publicado: (2020)

A Nomogram for Prediction of Overall Survival in Patients with Node-negative Gallbladder Cancer
por: Chen, Mingyu, et al.
Publicado: (2019)

Prediction of postoperative survival of triple-negative breast cancer based on nomogram model combined with expression of HIF-1α and c-myc
por: Cui, Jianxiu, et al.
Publicado: (2019)

Prognostic and predictive value of Ki-67 in triple-negative breast cancer
por: Wang, Wei, et al.
Publicado: (2016)

Nomograms to estimate long-term overall survival and breast cancer-specific survival of patients with luminal breast cancer
por: Sun, Wei, et al.
Publicado: (2016)

Computerized Assessment of the Tumor-stromal Ratio and Proposal of a Novel Nomogram for Predicting Survival in Invasive Breast Cancer
por: Qian, Xu, et al.
Publicado: (2021)

A novel conditional survival nomogram for monitoring real-time prognosis of non-metastatic triple-negative breast cancer
por: Meng, Xiangdi, et al.
Publicado: (2023)

Predicting response and survival in chemotherapy-treated triple-negative breast cancer
por: Prat, A, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_maj0clhjbn2a2t2vvb4avaluu6